ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,680,199 | -16.6% | 6,570,939 | +2.9% | 0.43% | -5.1% |
| Q2 2023 | $42,773,115 | -4.2% | 6,384,047 | +19.9% | 0.45% | -12.6% |
| Q1 2023 | $44,656,077 | +9.6% | 5,322,536 | -0.6% | 0.52% | -12.3% |
| Q4 2022 | $40,731,117 | +22.5% | 5,352,315 | +10.6% | 0.59% | +38.1% |
| Q3 2022 | $33,238,000 | -8.0% | 4,838,191 | +4.8% | 0.42% | -4.7% |
| Q2 2022 | $36,116,000 | -36.1% | 4,618,399 | +11.5% | 0.45% | +7.5% |
| Q1 2022 | $56,522,000 | -35.1% | 4,140,778 | +31.0% | 0.42% | -9.4% |
| Q4 2021 | $87,052,000 | +30.3% | 3,160,923 | +55.9% | 0.46% | +59.6% |
| Q3 2021 | $66,826,000 | -6.3% | 2,027,478 | +13.8% | 0.29% | +2.9% |
| Q2 2021 | $71,289,000 | +344.0% | 1,782,219 | +346.9% | 0.28% | +253.2% |
| Q1 2021 | $16,056,000 | +20.8% | 398,810 | +77.4% | 0.08% | +5.3% |
| Q4 2020 | $13,294,000 | +70.2% | 224,819 | +18.0% | 0.08% | +8.7% |
| Q3 2020 | $7,809,000 | +10.9% | 190,463 | +14.3% | 0.07% | -25.0% |
| Q2 2020 | $7,039,000 | – | 166,573 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |